Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS-CoV-2 vaccines in solid organ transplant recipients: A case series

Clin Transplant. 2022 Sep;36(9):e14772. doi: 10.1111/ctr.14772. Epub 2022 Jul 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Ad26COVS1
  • Antibodies, Viral
  • COVID-19 Vaccines
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Humans
  • Organ Transplantation* / adverse effects
  • RNA, Messenger
  • SARS-CoV-2 / genetics
  • Transplant Recipients

Substances

  • Ad26COVS1
  • Antibodies, Viral
  • COVID-19 Vaccines
  • RNA, Messenger